MAGE-B2 Activators
The chemical class termed MAGE-B2 Activators includes compounds that can modulate the activity or expression of the MAGE-B2 protein through indirect mechanisms. These chemicals target various signaling pathways and cellular processes, creating an environment that can influence MAGE-B2. Compounds like 5-Azacytidine and Trichostatin A, which affect DNA methylation and histone deacetylation, respectively, alter gene expression landscapes, impacting MAGE-B2 expression. Rapamycin and LY294002, targeting the mTOR and PI3K/AKT pathways, respectively, create conditions that may influence MAGE-B2's role in cell growth and metabolism. Additionally, PD98059, an MEK inhibitor affecting the MAPK/ERK pathway, and Forskolin, which elevates cAMP levels, could modify the cellular context in which MAGE-B2 operates, possibly affecting its expression or activity.
Other signaling molecules and inhibitors also contribute to creating a cellular milieu conducive to changes in MAGE-B2 activity. SB431542, a TGF-β receptor inhibitor, SP600125, a JNK inhibitor, Y-27632, a ROCK inhibitor, and BAY 11-7082, an NF-κB activation inhibitor, each modulate specific pathways or cellular aspects that could indirectly affect MAGE-B2. For instance, altering stress responses, cellular architecture, and inflammatory signals can impact MAGE-B2. Wortmannin and Lithium Chloride, influencing the PI3K/AKT and Wnt signaling pathways, respectively, can modify the cellular environment, affecting processes where MAGE-B2 is involved.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, altering the epigenetic landscape. This can lead to changes in gene expression, potentially affecting MAGE-B2 expression by modifying the epigenetic regulation of genes where MAGE-B2 is active. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, affecting chromatin structure and gene expression. This broad epigenetic modulation could indirectly influence MAGE-B2 expression by altering the transcriptional environment of its gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and metabolism. By impacting these cellular processes, rapamycin could create a context that indirectly affects MAGE-B2 expression or activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an MEK inhibitor, affects the MAPK/ERK pathway. Its influence on this pathway could create a cellular context affecting MAGE-B2, potentially altering its expression or activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP can modulate various signaling pathways that might intersect with MAGE-B2's function, particularly in cells where MAGE-B2 is expressed. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β receptor. While not directly involving MAGE-B2, inhibiting this pathway can alter the cellular environment, potentially affecting MAGE-B2 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, part of the MAPK signaling pathways. By inhibiting JNK, it could indirectly influence MAGE-B2's function or expression by altering stress and inflammatory response signals. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, impacting cell shape and motility. This could affect MAGE-B2 by altering cellular architecture and signaling related to cytoskeletal dynamics. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation, potentially influencing the expression of a range of genes, possibly including those related to MAGE-B2's function or expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, which can impact the AKT pathway and thereby potentially influence MAGE-B2 indirectly by altering cellular survival and proliferation signals. | ||||||